A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Associate Director/Director - Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • A Ph.D. or Master's degree in Biostatistics, Statistics, Mathematics, Medical Statistics, or a related quantitative discipline is required.
  • Associate Director candidates need 8+ years of biostatistics experience with a Ph.D. or 10+ years with a Master's degree in the pharmaceutical, biotechnology, CRO, or related life sciences industry.
  • Director candidates need 10+ years of biostatistics experience with a Ph.D. or 12+ years with a Master's degree in the pharmaceutical, biotechnology, CRO, or related life sciences industry.
  • Experience with clinical trial design, analysis, and reporting is required.
  • Experience in Phase III pivotal clinical development studies is required.
  • Strong statistical programming skills in SAS are required.
  • Ability to work on-site Monday, Tuesday, and Thursday is required; fully remote candidates are not considered.
  • Experience overseeing and managing CRO statistical analyses of assigned clinical trials is required.
  • Strong time and resource management skills to meet predetermined deadlines are required.
  • Flexibility in approach and ability to deliver high-quality work in a dynamic environment with competing priorities are required.
  • Excellent written and verbal communication and presentation skills are required.
  • Ability to effectively interact with internal team members and external parties who may not readily understand how statistics apply to drug development and study outcomes is required.

Responsibilities

  • Lead and manage statistical activities within clinical studies, including contributing to study design, selecting appropriate data analysis methods, and estimating sample size.
  • Partner with functional team members, external consultants, key opinion leaders, medical advisors, and CROs or contractors to maintain data quality and integrity and identify and minimize study or project risks.
  • Collaborate with external CRO partners and manage creation of study Statistical Analysis Plans based on regulatory guidance and sound statistical methodology, and creation of Table, Figure, and Listing shells according to study timelines.
  • Review Case Report Forms and supporting clinical trial documentation, including Protocol Deviation Plans and Data Management Plans.
  • Support clinical data reviews during trial conduct for data quality, outlier identification, trend analysis, and potential impact on trial results using SAS and data visualization software.
  • Perform hands-on quality checks of CRO deliverables using SAS and/or R.
  • Contribute to Clinical Study Report writing, including interpretation of trial results and quality checks of data presentations.
  • Contribute to regulatory submission documents, including Investigational New Drug applications, FDA meeting briefing materials, and New Drug Application submission documents, including eCRT packages.
  • Conduct ad hoc analyses using SAS and/or R in support of assigned projects.
  • Contribute to developing Standard Operating Procedures, Work Instructions, and templates within the function.
  • Ensure knowledge transfer during and at the completion of studies and projects.
  • Stay current with changes in statistics and implement new ideas and advanced processes where applicable.

Desired Qualifications

  • Modeling and simulation skills are preferred.
  • Experience preparing marketing application submissions to regulatory authorities is strongly preferred.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs